Violin Jonathan
SEC-identified person · CIK 1730615 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Glycomimetics INC GLYC | Director | filed 2025 - 2026 |
| Magenta Therapeutics, Inc. MGTA | Director | filed 2023 - 2026 |
| Catabasis Pharmaceuticals INC CATB | Director | filed 2021 - 2026 |
| Viridian Therapeutics, Inc.\DE VRDN | Director · See Remarks | filed 2020 - 2023 |
| Trevena INC TRVN | SVP-Scientific Affairs & IR | filed 2018 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.